Cases & Deals

Stilla Technologies raises €16 million in Series A round

Clients Stilla Technologies SAS

Jones Day represented Stilla Technologies SAS, the European provider of pioneering digital PCR solutions for high precision genetic analysis, in connection with its issuance of €16 million (US$18 million) of Series A Convertible Preferred Stock in a private placement to Illumina Ventures, Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds, and Idinvest Partners.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.